Ritodrine in oral maintenance of tocolysis after active preterm labor: Randomized controlled trial

Croatian Medical Journal

Volumn 47, Issue 1, 2006, Pages 25-31

  Matijević, Ratko ^a   Grgić, Ozren ^a   Vasilj, Oliver ^a  

^a Holy Ghost General Hospital   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

RITODRINE;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DYSPNEA; FEMALE; FETUS HEART RATE; HEART PALPITATION; HUMAN; HYPOTENSION; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREMATURE LABOR; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TACHYCARDIA; TOCOLYSIS; TREMOR; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; UTERUS CONTRACTION;

ADMINISTRATION, ORAL; ADULT; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RITODRINE; TOCOLYTIC AGENTS;

EID: 33644658515     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Holleboom CA, Merkus JM, van Elferen LW, Keirse MJ. Double-blind evaluation of ritodrine sustained, release for oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol. 1996;103:702-5.
2. Sayin NC, Varol FG, Balkanli-Kaplan P, Sayin M. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor. J Perinat Med. 2004;32:220-4.
3. Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev. 2002;(4):CD003933.
4. Kierse MJ, King GA. Preterm labour. In: Chalmers I, Enkin M, Kierse MJ, editors. Effective care in pregnancy and childbirth. Oxford: Oxford University Press; 1989. p. 694-754.
5. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol. 1999;181:484-90.
6. Meirowitz NB, Ananth CV, Smulian JC, Vintzileos AM. Value of maintenance therapy with oral tocolytics: a systematic review. J Matern Fetal Med. 1999;8:177-83.
7. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;(4):CD004352.
8. Cook CM, Peek MJ. Survey of the management of preterm labour in Australia and New Zealand in 2002. Aust N Z J Obstet Gynaecol. 2004;44:35-8.
9. Essed GG, Struyker Boudier HA, Van Zijl JA. Biopharmaceutical aspects of ritodrine retard in pregnant women. Arch Int Pharmacodyn Ther. 1988;293:295-300.
10. Essed GG, de Haan J, Struyker Boudier HA, van Elferen LW. A new administration form of ritodrine. Ritodrine plasma levels with sustained-release capsules in a steady state. Gynecol Obstet Invest. 1987;23:10-5.
11. Gokay Z, Ozcan T, Copel JA. Changes in fetal hemodynamics with ritodrine tocolysis. Ultrasound Obstet Gynecol. 2001:18:44-6.
12. Rozenberg P. Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review [In French]. J Gynecol Obstet Biol Reprod (Paris). 2001;30:221-30.
13. Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol. 2000;95:477-81.
14. Keirse MJ. Betamimetic drugs in the prophylaxis of preterm labour: extent and rationale of their use. Br J Obstet Gynaecol. 1984;91:431-7.
15. Lamont RF. Clinical perspectives on current opinion for treatment strategy. Research and Clinical Forums. 1994;16:139-54.
16. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2000;(2):CD000940.
17. Gaunekar NN, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2004;(3):CD004071.
18. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol. 1996;175:838-42.
19. Dodd JM, Crowther CA. Oral betamimetics for maintenance therapy after threatened preterm labour, (protocol for a Cochrane review). In: The Cochrane Library, Issue 2. Chichester (UK): Wiley; 2004.
20. Macones GA, Berlin M, Berlin JA. Efficacy oforal beta-agonist maintenance therapy in preterm labor: a meta-analysis. Obstet Gynecol. 1995:85:3137.
21. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 1992;327:30842.
22. King JF, Grant A, Keirse MJ, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 1988;95:211-22.
23. Gupta RC, Foster S, Romano PM, Thomas HM III. Acute pulmonary edema associated with the use of oral ritodrine for premature labor. Chest. 1989;95:479-81.
24. Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol. 1999;181:822-7.